Release date: 9/20/2024
Expiration date: 09/19/2027
Estimated Time of Completion: 1 hour
Description
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
Learning Objectives
After completing this case the reader should be able to:
- Recognize clinical features of hidradenitis suppurativa (HS).
- Describe the Hurley staging system for HS.
- Identify the lifestyle factors associated with increased severity of HS.
- Discuss the role of hormonal factors on the severity of HS and their impact on treatment options.
- Discuss the importance of topical treatments in the clinical management of HS.
- Summarize the various non-biologics available to treat HS.
- Summarize the various biologics available to treat HS.
- Describe the role of procedural interventions in the treatment of HS.
Target Audience
Directed to primary care physicians including family practitioners and internists.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
American Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Your credit will be reported to the ABIM within 30 days of claiming credit.
American Board of Anesthesiology (ABA) MOC
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
Maintenance of Certification in AnesthesiologyTM program and MOCA® are registered trademarks of The American Board of Anesthesiology®. MOCA 2.0® is a trademark of The American Board of Anesthesiology®.
Your credit will be reported to the ABA within 30 days of claiming credit.
American Board of Surgery (ABS) MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Activity Director and Faculty
Activity Director
Anthony Fernandez, MD, PhD
Director, Medical and Inpatient Dermatology
W.D. Steck Chair of Clinical Dermatology
Medical Co-Director, Center for Continuing Education
Cleveland Clinic
Cleveland, OH
Steven Kawczak, PhD, CHCP, FACEHP
Assistant Professor of Medicine, Cleveland Clinic Lerner College of Medicine of CWRU
Co-Director, Center for Continuing Education
Staff, Center for Educational Resources
Education Institute
Cleveland Clinic
Cleveland, OH
Faculty
Kathleen Coerdt, MD
Cleveland Clinic
Cleveland, OH
Michelle Kerns, MD
Department of Dermatology
Medical Specialty Institute
Cleveland Clinic
Cleveland, OH
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty has indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:
| Anthony Fernandez, MD, PhD |
Bristol-Myers Squibb Co., UCB, Inc. |
Consulting |
Pfizer, Inc. |
Research / Independent Contractor |
Mallinckrodt Inc., Novartis |
Consulting
Research / Independent Contractor
Teaching and Speaking |
Abbvie Pharmaceuticals |
Consulting
Research / Independent Contractor
Advisor or review panel participant
Teaching and Speaking |
Kyowa Kirin |
Teaching and Speaking |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Kathleen Coerdt, MD
Steven Kawczak, PhD
Michelle Kerns, MD
This CME activity was produced by The Cleveland Clinic
Center for Continuing Education.
